GT Biopharma (GTBP) News Today $3.01 -0.18 (-5.64%) (As of 01:40 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period GT Biopharma Reports Third Quarter 2024 Financial ResultsNovember 14, 2024 | globenewswire.comGT Biopharma (NASDAQ:GTBP) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comGT Biopharma to Participate in the 3rd Annual ROTH Healthcare Opportunities ConferenceSeptember 26, 2024 | globenewswire.comGT Biopharma to Host Virtual KOL Event Showcasing its NK Cell Engager Pipeline and Broad Indication Potential on October 10, 2024September 24, 2024 | globenewswire.comGT Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateAugust 15, 2024 | markets.businessinsider.comGT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ LeukemiaJune 27, 2024 | globenewswire.comGT Biopharma Shares Rise 16% After Direct Offering PricesMay 21, 2024 | marketwatch.comGT Biopharma Announces $3.2 Mln Direct Offering Of Shares; Stock UpMay 21, 2024 | markets.businessinsider.comGT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesMay 21, 2024 | globenewswire.comWhy Is GT Biopharma (GTBP) Stock Up 143% Today?May 20, 2024 | investorplace.comGT Biopharma, Inc. Common Stock (GTBP)May 18, 2024 | nasdaq.comRaymond W. Urbanski's Net WorthMay 16, 2024 | benzinga.comGTBP Stock Earnings: GT Biopharma Beats EPS for Q1 2024May 16, 2024 | investorplace.comGT Biopharma reports Q1 resultsMay 15, 2024 | msn.comGT Biopharma Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 15, 2024 | globenewswire.comRecap: GT Biopharma Q4 EarningsMarch 27, 2024 | benzinga.comGT Biopharma Reports Fourth Quarter and Full-Year 2023 Financial ResultsMarch 26, 2024 | globenewswire.comGT Biopharma (GTBP) Price Target Increased by 2900.00% to 153.00February 25, 2024 | msn.comGTBP Feb 2024 2.500 callFebruary 14, 2024 | finance.yahoo.comTrading was temporarily halted for "GTBP" at 07:02 PM with a stated reason of "News pending."February 5, 2024 | marketbeat.comGT Biopharma, Inc. (GTBP)February 2, 2024 | finance.yahoo.comGT Biopharma Announces Reverse Stock Split UpdateFebruary 2, 2024 | msn.comGT Biopharma Stock (NASDAQ:GTBP), Short Interest ReportFebruary 2, 2024 | benzinga.comGT Biopharma, Inc. Announces 1-for-30 Reverse Stock SplitFebruary 1, 2024 | finance.yahoo.comBuy Rating for GT Biopharma: High Efficacy and Expanded Potential in Oncology TherapeuticsDecember 14, 2023 | markets.businessinsider.comLeading Proxy Advisory Firms, ISS and Glass Lewis, Recommend GT Biopharma Stockholders Vote “FOR” All Proposed Items at the Upcoming Special Meeting of StockholdersDecember 6, 2023 | finance.yahoo.comGT Biopharma submits IND to FDA for CD33+ leukemia therapyDecember 4, 2023 | msn.comGT Biopharma Announces IND Submission for GTB-3650 for Treatment of CD33+ LeukemiaDecember 4, 2023 | finance.yahoo.comGT Biopharma: Strong Q3 Performance and Promising Pipeline Progression Justify Buy RatingNovember 23, 2023 | markets.businessinsider.comGT Biopharma Presented Positive Preclinical Data for GTB-5550, a Novel TriKE® Molecule for Targeted Prostate Cancer Treatment During the Society for Immunotherapy of Cancer (SITC) 2023 Annual MeetingNovember 6, 2023 | finance.yahoo.comGT Biopharma GAAP EPS of -$0.06November 1, 2023 | msn.comGT Biopharma Reports Third Quarter 2023 Financial ResultsNovember 1, 2023 | finance.yahoo.comGT Biopharma, Inc. (GTBP) May Find a Bottom Soon, Here's Why You Should Buy the Stock NowAugust 24, 2023 | finance.yahoo.comH.C. Wainwright Remains a Buy on GT Biopharma (GTBP)August 8, 2023 | markets.businessinsider.comGT Biopharma, Inc.: GT Biopharma Reports Second Quarter 2023 Financial ResultsAugust 7, 2023 | finanznachrichten.deGT Biopharma Reports Second Quarter 2023 Financial ResultsAugust 7, 2023 | finance.yahoo.comGT Biopharma to Participate in the H.C. Wainwright Immune Cell Engager Conference on August 17, 2023August 3, 2023 | finance.yahoo.comHere's Why GT Biopharma, Inc. (GTBP) Is a Great 'Buy the Bottom' Stock NowJune 2, 2023 | msn.comAll You Need to Know About GT Biopharma, Inc. (GTBP) Rating Upgrade to BuyMay 19, 2023 | msn.comHC Wainwright & Co. Reiterates GT Biopharma (GTBP) Buy RecommendationMay 18, 2023 | msn.comEF Hutton Reiterates GT Biopharma (GTBP) Hold RecommendationMay 17, 2023 | msn.comGT Biopharma, Inc.: GT Biopharma Reports First Quarter 2023 Financial Results and Provides Corporate UpdateMay 16, 2023 | finanznachrichten.deAnalysts Offer Insights on Healthcare Companies: Cara Therapeutics (CARA), GT Biopharma (GTBP) and Spruce Biosciences (SPRB)May 16, 2023 | markets.businessinsider.comGT Biopharma Reports First Quarter 2023 Financial Results and Provides Corporate UpdateMay 15, 2023 | finance.yahoo.comGT Biopharma (GTBP) Gets a Buy from H.C. WainwrightApril 3, 2023 | markets.businessinsider.comGT Biopharma Inc Up 20.52% To $0.56 After Earnings MissApril 2, 2023 | benzinga.comGT Biopharma, Inc.: GT Biopharma Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate UpdateApril 1, 2023 | finanznachrichten.deGT Biopharma Stock (NASDAQ:GTBP), DividendsApril 1, 2023 | benzinga.comEF Hutton Keeps Their Hold Rating on GT Biopharma (GTBP)March 31, 2023 | markets.businessinsider.comGT Biopharma Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate UpdateMarch 30, 2023 | finance.yahoo.com Get GT Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for GTBP and its competitors with MarketBeat's FREE daily newsletter. Email Address JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback. Get your free guide NOW before it's too late. GTBP Media Mentions By Week GTBP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GTBP News Sentiment▼0.000.47▲Average Medical News Sentiment GTBP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GTBP Articles This Week▼10▲GTBP Articles Average Week Get GT Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for GTBP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Jaguar Health News Kiora Pharmaceuticals News Marker Therapeutics News Lipocine News Natural Alternatives International News Pluri News Athira Pharma News GeoVax Labs News Equillium News Lakeshore Biopharma News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GTBP) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GT Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GT Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GTBP Stock Alerts